03.03.2015 08:15:37
|
DSM finalizes sale of Euroresins to Cathay Investments
Royal DSM, the global Life Sciences and Materials Sciences company, today announces it has finalized the sale of Euroresins to Cathay Investments. The divestment was announced on 23 December 2014.
Euroresins is a distributor of products to the composite resins industry with activities in nine countries in Europe. Euroresins realizes sales of approximately €90 million with around 70 employees.
Cathay Investments is the UK holding company for a group of companies engaged in chemical distribution and trading throughout the UK and Scandinavia. Since its establishment Cathay has grown its portfolio to six companies.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM has around 21,000 employees and delivers annual net sales of more than €9 billion. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
DSM Corporate Communications Herman Betten tel. +31 (0) 45 5782017 e-mail media.contacts@dsm.com | DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 e-mail investor.relations@dsm.com |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DSM NVmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DSM NVmehr Analysen
Aktien in diesem Artikel
DSM NV | 108,95 | -0,86% |
|